OptiBiotix Health (LON:OPTI) Announces Earnings Results

OptiBiotix Health (LON:OPTI) announced its quarterly earnings results on Thursday. The company reported GBX (1.52) EPS for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%.

OptiBiotix Health Trading Down 9.1%

LON OPTI traded down GBX 0.60 during trading hours on Thursday, hitting GBX 6. The company’s stock had a trading volume of 990,389 shares, compared to its average volume of 354,943. OptiBiotix Health has a 52 week low of GBX 4.50 and a 52 week high of GBX 12.25. The company has a market capitalization of £6.20 million, a PE ratio of -1.56 and a beta of 1.82. The company’s 50-day simple moving average is GBX 5.80 and its two-hundred day simple moving average is GBX 5.74.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.